Substrate
finance

SPDR Gold Trust Up 11% Year-to-Date Despite U.S.-Iran Conflict Volatility

The outbreak of war between the U.S. and Iran has introduced significant volatility to gold prices, contrasting with the metal's strong performance in 2025 and early 2026. Wells Fargo maintains that gold remains a compelling medium-term investment opportunity. Despite a sharp decline in March 2026, the SPDR Gold Trust has risen 11% year-to-date as of April.

Benzinga
1 source·Apr 21, 11:53 AM(14 days ago)·1m read
|
SPDR Gold Trust Up 11% Year-to-Date Despite U.S.-Iran Conflict VolatilitySubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

The U.S.-Iran conflict has contributed to recent fluctuations in gold prices. Benzinga reported that this geopolitical event has slowed gold's momentum in recent weeks, though institutions view it as part of a broader intact trajectory. The conflict's impact emerged amid gold's recovery from earlier setbacks.

Wells Fargo views gold as a compelling medium-term opportunity, rather than a trade that has run its course, according to Benzinga. This stance comes as the market navigates pressures driven by the U.S.-Iran war.

Gold's performance in March 2026 was the worst since 2008, as war-driven inflation erased rate cut expectations for gold. Benzinga noted that March's pullback marked a complete contrast to gold's prior blistering run. The SPDR Gold Trust (NYSE: GLD) is up 11% year-to-date as of April 2026, reflecting a market recovery since the March downturn.

The strength in gold from 2025 carried into early 2026 before sentiment shifted due to the war. Benzinga reported that the market has recovered following the March decline. This year-to-date gain in the SPDR Gold Trust underscores ongoing investor interest amid the volatility.

In 2025, gold rallied due to central bank purchases, inflation concerns, and geopolitical tensions. Benzinga described this period as one where gold was a standout performer fueled by strong central bank buying and lingering inflation worries. These factors contributed to the yellow metal's blistering run throughout the year, before the U.S.-Iran conflict reshaped the picture in 2026.

Benzinga emphasized that elevated geopolitical tensions were a key driver in 2025, which persisted as a supportive element for gold before the war's inflationary effects took hold in March 2026.

Key Facts

U.S.-Iran war outbreak
The war caused volatility in gold prices, contributing to a shift in market sentiment.
Wells Fargo's view
Wells Fargo sees gold as a compelling medium-term opportunity despite recent volatility.
March 2026 performance
Gold experienced its worst month since 2008 due to war-driven inflation erasing rate cut expectations.
2025 rally
Gold rallied in 2025 driven by central bank purchases, inflation concerns, and geopolitical tensions.
SPDR Gold Trust performance
The ETF is up 11% year-to-date as of April 2026, indicating recovery post-March decline.

Story Timeline

6 events
  1. 2026-04

    SPDR Gold Trust (NYSE: GLD) is up 11% year-to-date as of April 2026.

    1 sourceBenzinga
  2. 2026-03

    Gold's performance in March 2026 was the worst since 2008, as war-driven inflation erased rate cut expectations.

    1 sourceBenzinga
  3. 2026-early

    Gold's strength from 2025 carried into early 2026.

    1 sourceBenzinga
  4. 2026-03

    War-driven inflation in March 2026 erased rate cut expectations for gold.

    1 sourceBenzinga
  5. 2025

    In 2025, gold rallied due to central bank purchases, inflation concerns, and geopolitical tensions.

    1 sourceBenzinga
  6. Recent (post-2025)

    A U.S.–Iran war broke out, causing volatility in gold prices.

    1 sourceBenzinga

Potential Impact

  1. 01

    Continued volatility in gold prices due to ongoing U.S.-Iran war tensions.

  2. 02

    Inflation pressures from the war influencing broader commodity markets.

  3. 03

    Potential for increased investor interest in gold as a safe-haven asset amid geopolitical risks.

  4. 04

    Sustained central bank purchases supporting gold's medium-term trajectory.

  5. 05

    Recovery in gold ETFs like SPDR Gold Trust attracting more institutional bets.

Transparency Panel

Sources cross-referenced1
Framing risk0/100 (low)
Confidence score65%
Synthesized bySubstrate AI
Word count282 words
PublishedApr 21, 2026, 11:53 AM
Bias signals removed2 across 2 outlets
Signal Breakdown
Loaded 2

Related Stories

Oil Prices Drop After Reports of U.S.-Iran Talks on Ending War and Reopening Strait of HormuzJashuah / Wikimedia (CC BY-SA 3.0)
finance1 hr ago

Oil Prices Drop After Reports of U.S.-Iran Talks on Ending War and Reopening Strait of Hormuz

Oil prices dropped significantly following reports that the U.S. and Iran are close to a memorandum of understanding to halt fighting and begin nuclear talks. President Trump announced a pause in the U.S. naval escort operation in the Strait of Hormuz. Iran is expected to respond…

cnbc.com
DE
UN
3 sources
Crypto Firm World Liberty Financial Sues Investor Justin Sun Over Alleged Smear Campaigninsidermonkey.com
finance1 hr agoDeveloping

Crypto Firm World Liberty Financial Sues Investor Justin Sun Over Alleged Smear Campaign

World Liberty Financial, a cryptocurrency company founded by the Trump and Witkoff families, has filed a lawsuit accusing investor Justin Sun of conducting a smear campaign to harm its token's value. The suit claims Sun shorted the token in violation of agreements and used social…

Fox News
1 source
FDA Withdraws Studies Supporting Safety of COVID and Shingles VaccinesThe U.S. Food and Drug Administration / Wikimedia (Public domain)
finance1 hr ago

FDA Withdraws Studies Supporting Safety of COVID and Shingles Vaccines

The U.S. Food and Drug Administration blocked the publication of research finding rare side effects from COVID and shingles vaccines. The studies were withdrawn due to broad conclusions not supported by data, amid broader efforts by the Trump administration to challenge vaccine r…

cnbc.com
The New York Times
Forbes
3 sources